EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).
April-Monn SL, Andreasi V, Schiavo Lena M, Sadowski MC, Kim-Fuchs C, Buri MC, Ketkar A, Maire R, Di Domenico A, Schrader J, Muffatti F, Doglioni C, Partelli S, Falconi M, Perren A, Marinoni I.
April-Monn SL, et al. Among authors: perren a.
Cancers (Basel). 2021 Oct 7;13(19):5014. doi: 10.3390/cancers13195014.
Cancers (Basel). 2021.
PMID: 34638497
Free PMC article.